文献速递慢性肾脏病

通过增强实验室报告附加信息与随访流程改善基层慢性肾脏病管理

Improving the management of chronic kidney disease in primary care by enhancing laboratory reports with additional information and follow-up procedures.
PubMed 文献 · Kidney Int · 2024-01-01

ASSIST-CKD试验评估向英国基层医生提供图形化eGFR报告对晚期转诊肾内科的影响,数据来自英国肾脏登记系统。试验结果虽为中性,但提供了干预效应的有用估计,并揭示了在繁忙医疗环境中实施复杂干预的挑战,可指导未来干预设计。

要点

  • 图形化eGFR报告干预未显著减少晚期转诊肾内科。
  • 试验数据为干预效应提供了有用估计。
  • 复杂干预在基层实施面临挑战,需优化设计。

核心结论

  • 图形化eGFR报告干预对晚期转诊肾内科的效果为中性。

研究设计与样本

  • ASSIST-CKD试验,数据来自英国肾脏登记系统,评估图形化eGFR报告对基层医生管理慢性肾脏病的影响。

主要发现

  • 试验结果中性,但数据提供了干预效应的有用估计。

临床怎么用

  • 图形化eGFR报告可作为基层慢性肾脏病管理的参考工具,但需结合随访流程优化。

局限性

  • 在繁忙医疗环境中实施复杂干预存在挑战,可能影响试验效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Identifying people at risk for progressive chronic kidney disease and connecting them with recommended care is crucial for providing timely and optimal treatment. The ASSIST-CKD (A programme to Spread eGFR [estimated glomerular filtration rate] graph Surveillance for the early identification, Support and Treatment of people with progressive CKD [chronic kidney disease]) trial evaluated the effect of graphical eGFR reporting to primary care physicians on late presentation to a nephrologist in the United Kingdom. Trial data were obtained from the UK Renal Registry. Although the results were neutral, the data generated from the ASSIST-CKD trial are informative and provide useful estimates of the intervention effect. The trial also provides valuable insights into the challenges of implementing complex interventions in busy health care environments, which can be used to guide the designs of future interventions.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Garg AX, Young A. Improving the management of chronic kidney disease in primary care by enhancing laboratory reports with additional information and follow-up procedures. Kidney Int. 2024. PMID: 39174199. doi:10.1016/j.kint.2024.07.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。